Form 8-K - Current report:
SEC Accession No. 0001079973-24-000635
Filing Date
2024-05-02
Accepted
2024-05-02 08:00:11
Documents
17
Period of Report
2024-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 32053
2 PROMISSORY NOTE ex4x1.htm EX-4.1 44314
3 AMENDED AND RESTATED CONVERTABLE PROMISSORY NOTE ex4x2.htm EX-4.2 85465
4 NOTE PURCHASE AGREEMENT ex10x1.htm EX-10.1 27509
  Complete submission text file 0001079973-24-000635.txt   445223

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE scpx-20240501.xsd EX-101.SCH 3549
6 XBRL DEFINITION FILE scpx-20240501_def.xml EX-101.DEF 26579
7 XBRL LABEL FILE scpx-20240501_lab.xml EX-101.LAB 36527
8 XBRL PRESENTATION FILE scpx-20240501_pre.xml EX-101.PRE 25203
20 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24905386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)